Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Stephen Larsen

1PUBLICATIONS

10CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 25, 2021

Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes.

Guillermo Garcia-Manero, Valeria Santini, Antonio Almeida

Pageof 1

Frequent Collaborators

1 joint publications

Guillermo Garcia-Manero

1 joint publications

Valeria Santini

1 joint publications

Gianluigi Reda

1 joint publications

Francesco Buccisano

1 joint publications

David Valcarcel

1 joint publications

Paresh Vyas

1 joint publications

Esther Natalie Olíva

1 joint publications

Jake Shortt

1 joint publications

Dietger Niederwieser

1 joint publications

Eric Laille

Frequent Collaborators

1 joint publications

Guillermo Garcia-Manero

1 joint publications

Valeria Santini

1 joint publications

Gianluigi Reda

1 joint publications

Francesco Buccisano

Top Related Videos

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

See more related videos

Top Related Videos

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

See more related videos